Sequenom (SQNM) Tops Q3 EPS by 4c

Sequenom (NASDAQ: SQNM) reported Q3 EPS of ($0.05), $0.04 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $42.8 million.

"We are encouraged by our progress towards the Company's goal to improve operations and cash flow. Sequenom continues to focus on obtaining profitable units while also achieving significant cost reductions in our operations," said Bill Welch, Chief Executive Officer of Sequenom, Inc. "In addition to focusing on profitable samples, we believe testing volumes were impacted by increased competitive activity, likely a consequence of changes of NIPT service providers by the two national reference laboratories. While early, testing volumes in the fourth quarter have increased to record levels."

For earnings history and earnings-related data on Sequenom (SQNM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Sinda raises $331M in IPO, reports Q2 net loss of $16.6M